Kidney International

TABLE 2

FROM:

Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension

Arlene B Chapman, Gary L Schwartz, Eric Boerwinkle and Stephen T Turner

BACK TO ARTICLE

Table 2. Subject characteristics measured at study enrollment

 African AmericanCaucasian 
CharacteristicMaleFemaleMaleFemale P value
Number82143158122 
Age years 48.2plusminus6.847.6plusminus5.748.2plusminus8.250.1plusminus6.1<0.040
Weight kg 94.2plusminus19.288.7plusminus20.597.8plusminus17.5b 83.3plusminus16.4<0.001
BMI29.8plusminus5.132.9plusminus7.2b 30.5plusminus4.930.8plusminus5.4<0.001
Waist:hip0.92plusminus0.1b 0.84plusminus0.10.97plusminus0.1a,b 0.89plusminus0.1a <0.0001
Age HT Dx40.2plusminus9.439.1plusminus8.541.8plusminus10.745.8plusminus6.0a,b <0.0001
HT duration years 8.8plusminus8.6a 8.1plusminus7.2a 5.8plusminus6.93.7plusminus5.0<0.0001
% on Rx8896b 9097b 0.038
Rx duration years 7.0plusminus7.66.9plusminus6.4a 5.0plusminus5.93.7plusminus4.6<0.0001
% on K+ 2639a,b 716a,b <0.0001
% Smoker22a 13a 74<0.001
% Etoh user62b 3983a 82a <0.0001
% College grad393145b 30<0.035
% Menopause 58 660.328
% HRT 37 67a <0.001

 Abbreviations are: BMI, body mass index [weight (kg) ÷ height squared (m2)]; waist:hip, waist-to-hip ratio; HT, hypertension; Dx, diagnosis; Rx, antihypertensive drug treatment; K+, potassium supplementation; Etoh, ethanol; HRT, hormone replacement therapy.

a Significant difference between races within genders

b Significant difference between genders within races

BACK TO ARTICLE